XXII : Summary for 22nd Century Group, Inc. Common - Yahoo Finance

U.S. Markets closed

22nd Century Group, Inc. (XXII)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.94+0.00 (+0.43%)
At close: 4:01PM EST
People also watch
CARAKSHBTURVCGRWTRTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.94
Open0.95
Bid0.00 x
Ask0.00 x
Day's Range0.91 - 0.95
52 Week Range0.71 - 1.71
Volume592,349
Avg. Volume1,092,162
Market Cap85.26M
Beta2.15
PE Ratio (TTM)-6.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to 22nd Century Group, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to 22nd Century Group, Inc. Here are 5 ETFs with the largest exposure to XXII-US. Comparing the performance and risk of 22nd Century Group, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Business Wire17 days ago

    FDA Provides Positive and Encouraging Feedback for 22nd Century’s Very Low Nicotine MRTPA Filings

    22nd Century Group, Inc. , a plant biotechnology company that is focused on reducing the harm caused by smoking, today announced that the U.S. Food and Drug Administration has provided the Company with helpful and positive feedback on the Company’s combined Modified Risk Tobacco Product Applications and Premarket Tobacco Product Applications for 22nd Century’s “BRAND A” Very Low Nicotine tobacco cigarettes....

  • Business Wirelast month

    22nd Century Group Announces Major Scientific Collaboration with University of Virginia

    22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has entered into a sponsored research agreement with the University of Virginia and an exclusive license with the University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group .